Approximately 1 in 10000 people have hemophilia A102023 715 PM US Food and Drug Administration Approves BioMarins ROCTAVIAN valoctocogene roxaparvovecrvox the First and Only Gene Thera httpsinvestorsbiomarincom20230629USFoodandDrugAdministrationApprovesBioMarinsROCTAVIANTMvaloctocogeneroxaparvovecrvoxtheF 611People living with hemophilia A lack sufficient functioning FVIII protein to help their blood clot and are at risk for painful andor potentially lifethreatening bleeds from even modest injuries